X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hipertensió pulmonar (20) 20
pulmonary hypertension (17) 17
hypertension (7) 7
index medicus (7) 7
humans (6) 6
hypertension, pulmonary (6) 6
male (6) 6
medicine (6) 6
female (5) 5
pulmonary artery (5) 5
aged (4) 4
diagnosis (4) 4
hypertension, pulmonary - physiopathology (4) 4
lung diseases (4) 4
middle aged (4) 4
chronic obstructive pulmonary diseases (3) 3
clinical trials (3) 3
malalties pulmonars obstructives cròniques (3) 3
patients (3) 3
pulmonary circulation (3) 3
research article (3) 3
risk factors (3) 3
therapy (3) 3
adult (2) 2
assaigs clínics (2) 2
biology and life sciences (2) 2
biomarkers (2) 2
blood (2) 2
cells (2) 2
chronic obstructive pulmonary disease (2) 2
cigarette smoking (2) 2
ciències de la salut (2) 2
cor (2) 2
diseases of the respiratory system (2) 2
endothelial cells (2) 2
endothelium (2) 2
expression (2) 2
fibrosi pulmonar (2) 2
hemodynamics (2) 2
hipertensión pulmonar (2) 2
hospitals (2) 2
hypertension, pulmonary - diagnosis (2) 2
hypertension, pulmonary - drug therapy (2) 2
hypertension, pulmonary - metabolism (2) 2
hàbit de fumar (2) 2
kinases (2) 2
lungs (2) 2
lupus (2) 2
malalties (2) 2
malalties de l'aparell respiratori (2) 2
medicine and health sciences (2) 2
multidisciplinary sciences (2) 2
pathophysiology (2) 2
progenitor cells (2) 2
pulmonary arteries (2) 2
pulmonary disease, chronic obstructive - physiopathology (2) 2
pulmonary fibrosis (2) 2
respiratory organs diseases (2) 2
respiratory system (2) 2
science (2) 2
smoking (2) 2
stem cells (2) 2
tobbacco habit (2) 2
610 medicine & health (1) 1
615 - farmacologia. terapèutica. toxicologia. radiologia (1) 1
616.2 - patologia de l'aparell respiratori (1) 1
[ sdv ] life sciences [q-bio] (1) 1
[ sdv.mhep ] life sciences [q-bio]/human health and pathology (1) 1
abridged index medicus (1) 1
ac133 antigen (1) 1
acid (1) 1
activation (1) 1
administració de medicaments (1) 1
administration of drugs (1) 1
administration, oral (1) 1
adult stem cells (1) 1
advanced copd (1) 1
albuminuria (1) 1
ambrisentan (1) 1
amino acids (1) 1
analysis (1) 1
analytical chemistry (1) 1
anatomy (1) 1
angiogenesis (1) 1
animal cells (1) 1
animals (1) 1
animals de laboratori (1) 1
antigens, cd - metabolism (1) 1
antigens, cd34 - metabolism (1) 1
antihypertensive agents - administration & dosage (1) 1
antihypertensive agents - adverse effects (1) 1
antihypertensive agents - therapeutic use (1) 1
arterial stiffness (1) 1
arteries (1) 1
artery pressure (1) 1
assaigs clínics de medicaments (1) 1
autoimmune diseases (1) 1
bile (1) 1
bile ducts - physiopathology (1) 1
biochemistry (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2007, Clinics in chest medicine, ISBN 9781416042853, Volume 28, no. 1., xvi, 277
Book
1984, ISBN 0898386322, xiv, 373
Book
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 834 - 844
Patients with previously untreated pulmonary arterial hypertension who were randomly assigned to combination therapy with ambrisentan and tadalafil had a... 
INHALED ILOPROST | SURVIVAL | TRIAL | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | EPOPROSTENOL | COMBINATION THERAPY | HEART-FAILURE | DOUBLE-BLIND | BOSENTAN | Hypertension, Pulmonary - mortality | Double-Blind Method | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Hypertension, Pulmonary - physiopathology | Male | Hospitalization | Disease Progression | Tadalafil | Phenylpropionates - therapeutic use | Peptide Fragments - blood | Adult | Female | Phenylpropionates - adverse effects | Aged | Hypertension, Pulmonary - drug therapy | Drug Therapy, Combination | Carbolines - therapeutic use | Carbolines - adverse effects | Natriuretic Peptide, Brain - blood | Pyridazines - adverse effects | Pyridazines - therapeutic use | Symptomatology | Care and treatment | Usage | Analysis | Clinical trials | Dosage and administration | Pulmonary hypertension | Ambrisentan | Hypertension | Edema | Brain natriuretic peptide | Headache | Functional morphology | Pulmonary arteries | Lung diseases | Drug therapy | Patients | Clinical outcomes | Drug side effects | Assaigs clínics de medicaments | Efectes secundaris dels medicaments | Hipertensió pulmonar | Drug testing | Life Sciences | Human health and pathology | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
1984, ISBN 0879932066, xiv, 442
Book
PLoS ONE, ISSN 1932-6203, 08/2014, Volume 9, Issue 8, p. e106163
Background: In chronic obstructive pulmonary disease (COPD), decreased progenitor cells and impairment of systemic vascular function have been suggested to... 
MOBILIZATION | ARTERIAL STIFFNESS | SMOKERS | MULTIDISCIPLINARY SCIENCES | BONE-MARROW | TNF-ALPHA | HYPERTENSION | EXPRESSION | CARDIOVASCULAR RISK | ENDOTHELIAL GROWTH-FACTOR | COPD | Antigens, CD34 - metabolism | Leukocyte Common Antigens - metabolism | Humans | Middle Aged | Glycoproteins - metabolism | Hematopoietic Stem Cells - pathology | Hypertension, Pulmonary - physiopathology | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Pulmonary Disease, Chronic Obstructive - pathology | Antigens, CD - metabolism | Neovascularization, Pathologic - pathology | Peptides - metabolism | Female | Neovascularization, Pathologic - physiopathology | Pulmonary Disease, Chronic Obstructive - metabolism | Endothelium, Vascular - physiopathology | Hematopoietic Stem Cells - metabolism | Hypertension, Pulmonary - metabolism | AC133 Antigen | Endothelium, Vascular - metabolism | Aged | Neovascularization, Pathologic - metabolism | Hypertension, Pulmonary - pathology | Smoking | Flow cytometry | C-reactive protein | Interleukin | Impairment | Family medical history | Kinases | Risk factors | CD45 antigen | Arteries | Interleukin 6 | Angiogenesis | Fibrinogen | Bone marrow | Tumor necrosis factor-TNF | Chronic obstructive pulmonary disease | Vascular endothelial growth factor | Hypertension | CD34 antigen | Pulmonary arteries | Lung diseases | Health risks | Risk analysis | Cigarette smoking | Patients | Progenitor cells | Hemopoiesis | Medicine | Cytometry | Hospitals | Medical prognosis | Obstructive lung disease | Cells (biology) | Dilation | Pulmonary circulation | Cardiovascular diseases | Veins & arteries | Case studies | Malalties cardiovasculars | Tobbacco habit | Estudi de casos | Malalties pulmonars obstructives cròniques | Hipertensió pulmonar | Chronic obstructive pulmonary diseases | Pulmonary hypertension | Hàbit de fumar
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 08/2018, Volume 16, Issue 1, pp. 228 - 9
Background: There is increasing interest in using extracellular vesicle-derived microRNAs (miRNAs) as biomarkers in renal dysfunction and injury. Preliminary... 
Hypertension | Albuminuria | Exosomes | Urinary biomarkers | MicroRNAs | microRNAs | TARGET | MEDICINE, RESEARCH & EXPERIMENTAL | EVENTS | SIGNATURES | RISK | INDIVIDUALS | BIOMARKERS | LUPUS | MICROALBUMINURIA | EXPRESSION | Genetic aspects | MicroRNA | Research | Gene expression | Lupus | Urine | Biomarkers | Extracellular matrix | Blood pressure | Diabetes
Journal Article
International Journal of COPD, ISSN 1176-9106, 07/2015, Volume 10, pp. 1313 - 1320
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, pp. e0160505 - e0160505
Journal Article
Hepatology, ISSN 0270-9139, 10/2013, Volume 58, Issue 4, pp. 1424 - 1435
Journal Article
La hipertensión pulmonar (HP) se define por la presencia de una presión arterial pulmonar media (PAPm) mayor de 25 mmHg en reposo o de más de 30 mmHg durante... 
Tècniques no invasives d'exploració clínica | Patologia cardiovascular | 615 - Farmacologia. Terapèutica. Toxicologia. Radiologia | Ciències de la Salut | Estudis hemodinàmics | Hipertensió pulmonar
Dissertation
American Journal of Stem Cells, ISSN 2160-4150, 2015, Volume 4, Issue 1, pp. 13 - 21
Pulmonary artery remodelling it is a major feature of pulmonary hypertension (PH). It is characterised by cellular and structural changes of the pulmonary... 
Cellular reprogramming | Endothelial to mesenchymal transition | Remodelling | Endothelial cells | Pulmonary hypertension | Cèl·lules | Hipertensió pulmonar | Cells | Endoteli | Endothelium
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.